Inventor · disambiguated record
Christofer Tautermann
Also filed as: TAUTERMANN CHRISTOFER · TAUTERMANN CHRISTOFER SIEGFRIED
8 granted patents·2 pending applications·29 citations·filing 2010–2023
84Inventor score
Top patents by PatentIndex Score
10 records- 0191US11046706B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2018·Granted Jun 29, 2021·3 cites·26 claims
- 0291US10196402B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2017·Granted Feb 5, 2019·7 cites·31 claims
- 0389US11731981B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2021·Granted Aug 22, 2023·1 cites·20 claims
- 0489US9670222B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2014·Granted Jun 6, 2017·9 cites·23 claims
- 0588US8765949B2CCR2 receptor antagonists and uses thereofEBEL HEINER·Filed 2010·Granted Jul 1, 2014·9 cites·39 claims
- 0686US12209094B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2023·Granted Jan 28, 2025·0 cites·20 claims
- 0765US2023355638A1Cyclopentathiophene Carboxamide Derivatives as Platelet Activating Factor Receptor AntagonistsBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 0861US11766443B2Cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonistsBOEHRINGER INGELHEIM INT·Filed 2021·Granted Sep 26, 2023·0 cites·34 claims
- 0960US2025340546A1Hsd17b13 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 1057US11992494B2Cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonistsBOEHRINGER INGELHEIM INT·Filed 2022·Granted May 28, 2024·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Christofer Tautermann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →